W. Douglas Sheffield
Vice President, Clinical Research
Graduate Group: Pathology
Thesis Topic: Pathogenesis of experimental autoimmune encephalomyelitis
Dr. Sheffield has over 25 years experience directing the research and development of medical devices, biologies and pharmaceutical products. Previously, he was Director of New Technologies at Northstar Neuroscience, Inc., a Seattle-based medical device company seeking to improve neurological recovery following stroke through targeted electrical stimulation of the brain. While at Northstar, Dr. Sheffield was responsible for leading the stroke recovery program that developed a cortical stimulation technology to enhance post-stroke motor and language recovery. Additionally, he was responsible for the design and execution of all preclinical safety studies. Prior to this, Dr. Sheffield was with Johnson & Johnson where he was Ethicon's Director of Pharmaceutical Research and Development, responsible for developing th Regranex and Interceed technologies. He also served as Director of Surigcal R&D at Ethicon Endo-Surgery, leading to the development of numerous minimally invasive procedures. Dr. Sheffield is an inventor with multiple patents relating to medical devices and has authored and co-authored numerous medical publications.